LinkOPH

A 32-year-old pregnant woman at 31 weeks’ gestational age was referred to the New England Eye Center for a 1-week history of floaters and decreased vision in the left eye. She complained of 1 day of photophobia and left eye pain.Ocular history was unremarkable. Medical history included prior cesarean section, hepatitis C and spinal desmoid tumors resected and treated with doxorubicin. She had a history of intravenous drug use and stated the last episode was 8 months before presentation. She lived in a rural area with exposure to many animals including cats, dogs and horses and had removed ticks from her skin over the past year.

Read more →

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016, at 11:30 a.m. Pacific Time in San Francisco. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acad

Read more →

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that the U.S. Food and Drug Administration (FDA) is allowing the company to move forward with activities to begin a U.S. Investigational New Drug (IND) Phase II study of its Travoprost Intraocular Implant with the iDose™ delivery s

Read more →

Dry eye is a multifactorial progressive disease that worsens with time. At the European Society of Cataract and Refractive Surgeons meeting in Barcelona, Ocular Surgery News convened anterior segment surgeons from both sides of the Atlantic to address …

Read more →